Detalles de la búsqueda
1.
Evaluation of European LeukemiaNet 2022 risk classification in patients undergoing allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia: Identification of a very poor prognosis genetic group.
Br J Haematol
; 2024 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38811025
2.
Endothelial Activation and Stress Index in adults undergoing allogeneic hematopoietic cell transplantation with post-transplant cyclophosphamide-based prophylaxis.
Cytotherapy
; 26(1): 73-80, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37952139
3.
Impact of letermovir prophylaxis in CMV reactivation and disease after allogenic hematopoietic cell transplantation: a real-world, observational study.
Ann Hematol
; 103(2): 609-621, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37957371
4.
Differential protein expression in endothelial cells exposed to serum from patients with acute graft-vs-host disease, depending on steroid response.
J Cell Mol Med
; 27(9): 1227-1238, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37016544
5.
Prolactin, a potential biomarker for chronic GVHD activity.
Eur J Haematol
; 106(2): 158-164, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33047394
6.
Effect of pre-transplant JAK1/2 inhibitors and CD34 dose on transplant outcomes in myelofibrosis.
Eur J Haematol
; 107(5): 517-528, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34260760
7.
Less Is More: Superior Graft-versus-Host Disease-Free/Relapse-Free Survival with Reduced-Intensity Conditioning and Dual T Cell Depletion in Acute Myelogenous Leukemia.
Biol Blood Marrow Transplant
; 26(8): 1511-1519, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32422253
8.
Successful treatment of refractory red cell aplasia after allogeneic hematopoietic cell transplantation with daratumumab.
Eur J Haematol
; 104(2): 145-147, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31693245
9.
Impact of CD34+ cell dose on reduced intensity conditioning regimen haploidentical hematopoietic stem cell transplantation.
Eur J Haematol
; 104(1): 36-45, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31549435
10.
Clinicopathologic features and prognostic significance of CD30 expression in de novo diffuse large B-cell lymphoma (DLBCL): results in a homogeneous series from a single institution.
Biomarkers
; 25(1): 69-75, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31752540
11.
Autologous hematopoietic cell transplantation for T-cell prolymphocytic leukemia: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT.
Haematologica
; 109(5): 1608-1613, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38205539
12.
Reduced-intensity conditioning allogeneic transplant with dual T-cell depletion in myelofibrosis.
Eur J Haematol
; 103(6): 597-606, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31514253
13.
Reduced intensity allogeneic stem cell transplant with anti-thymocyte globulin and post-transplant cyclophosphamide in acute myeloid leukemia.
Eur J Haematol
; 103(5): 510-518, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31449699
14.
Reduced-Intensity Conditioning and Dual T Lymphocyte Suppression with Antithymocyte Globulin and Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplants for Hematological Malignancies.
Biol Blood Marrow Transplant
; 24(11): 2259-2264, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30009980
15.
Graft-versus-Host Disease-Free Relapse-Free Survival Definition for Patients with Nonmalignant Hematologic Disorders.
Biol Blood Marrow Transplant
; 26(2): 428, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31655120
16.
Impressive Graft-versus-Host Disease-Free, Relapse-Free Survival in Matched Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced-Intensity Conditioning and a Combination of Antithymocyte Globulin and Post-Transplantation Cyclophosphamide.
Biol Blood Marrow Transplant
; 25(11): e352-e353, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31279750
17.
Dual T Cell Depletion with Anti-Thymocyte Globulin and Post-Transplant Cyclophosphamide Results in Low Rates of Cytokine Release Syndrome in Peripheral Blood Haplo-Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 25(12): e387-e388, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31525491
18.
Easix Score Correlates With Endothelial Dysfunction Biomarkers and Predicts Risk of Acute Graft-Versus-Host Disease After Allogeneic Transplantation.
Transplant Cell Ther
; 30(2): 187.e1-187.e12, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38000709
19.
Post-Transplantation Cyclophosphamide and Tacrolimus for Graft-versus-Host Disease Prevention after Allogeneic Hematopoietic Cell Transplantation from HLA-Matched Donors Has More Advantages Than Limitations.
Transplant Cell Ther
; 30(2): 213.e1-213.e12, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38042256
20.
EASIX and cardiac adverse events after allogeneic hematopoietic cell transplantation.
Bone Marrow Transplant
; 2024 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38521885